前交叉韧带缺陷与完整膝关节单髁置换术后患者可接受症状状态的配对分析
本研究纳入114例因孤立性内侧膝骨关节炎行单髁置换术(UKA)的患者,比较前交叉韧带(ACL)缺陷与完整两组达到患者可接受症状状态(PASS)的比例。结果显示两组10年假体生存率均为97%,KOOS日常生活活动(ADL)的PASS达标率分别为87%和85%,所有结局指标均无显著差异。
要点
- ACL缺陷与完整组UKA术后10年生存率均为97%,平均生存时间无显著差异(p=0.878)。
- ACL缺陷组87%、ACL完整组85%达到KOOS ADL的PASS,所有KOOS子量表及Lysholm评分达标率无显著差异。
- 固定 bearing、内侧、非机器人辅助UKA在ACL缺陷与完整膝关节中均获得良好中期生存和PASS达标率。
核心结论
- ACL缺陷与完整组UKA术后PASS达标率及假体生存率均无显著差异,支持对ACL缺陷的内侧单间室骨关节炎行UKA。
研究设计与样本
- 配对分析,纳入114例因孤立性内侧膝骨关节炎行UKA的患者,平均年龄65岁(SD 10),排除近5年行ACL重建者。
主要发现
- ACL缺陷组10年生存率97%,平均生存16.1年(95%CI 15.3–16.8);ACL完整组10年生存率97%,平均生存15.6年(95%CI 14.8–16.361),p=0.878。
- ACL缺陷组平均随访9年(SD 3.5),32例(87%)达到KOOS ADL的PASS;ACL完整组平均随访8.6年(SD 3),63例(85%)达到PASS。
- 两组在所有KOOS子量表和Lysholm评分的PASS达标百分比上均无显著差异。
关键数值与推荐
- PASS阈值采用KOOS ADL评分87.5,参照全膝关节置换术(TKA)的报道。
- 失败定义为转为TKA。
临床怎么用
- 对于孤立性内侧膝骨关节炎伴ACL缺陷的患者,UKA可获得与ACL完整者相似的PASS达标率和中期假体生存率。
- PASS有助于医患沟通,改善单间室骨关节炎的手术管理决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The patient-acceptable symptom state (PASS) is a level of wellbeing, which is measured by the patient. The aim of this study was to determine if the proportion of patients who achieved an acceptable level of function (PASS) after medial unicompartmental knee arthroplasty (UKA) was different based on the status of the anterior cruciate ligament (ACL) at the time of surgery. METHODS: A total of 114 patients who underwent UKA for isolated medial osteoarthritis (OA) of the knee were included in the study. Their mean age was 65 years (SD 10). No patient underwent a bilateral procedure. Those who had undergone ACL reconstruction during the previous five years were excluded. The Knee injury Osteoarthritis Outcome Score Activities of Daily Living (KOOS ADL) function score was used as the primary outcome measure with a PASS of 87.5, as described for total knee arthroplasty (TKA). Patients completed all other KOOS subscales, Lysholm score, the Western Ontario and McMaster Universities Osteoarthritis Index, and the Veterans Rand 12-item health survey score. Failure was defined as conversion to TKA. RESULTS: Survivorship at ten years was 97% in both the ACL-deficient and ACL-intact groups. The mean survival was 16.1 years (95% confidence interval (CI) 15.3 to 16.8) for the ACL-deficient group and 15.6 years (95% CI 14.8 to 16.361) for the ACL-intact group (p = 0.878). At a mean of nine years (SD 3.5) in the ACL-deficient group, 32 patients (87%) reached the PASS for the KOOS ADL. In the ACL-intact group, at a mean of 8.6 years (SD 3) follow-up, 63 patients (85%) reached PASS for the KOOS ADL. There was no significant difference in the percentage of patients who reached PASS for all KOOS subscales and Lysholm between the two groups. CONCLUSION: PASS was achieved in 85% of all UKAs for KOOS ADL, similar to reports for TKA. Fixed-bearing, medial, non-robotically-assisted UKA resulted in 97% survival at ten years in both the ACL-deficient and ACL-intact groups. There was no significant difference in all outcomes between the two groups. Understanding PASS will allow better communication between surgeons and patients to improve the surgical management of patients with single compartment OA of the knee. This study provides mid- to long-term data supporting the use of PASS to document outcomes following UKA. PASS was met in more than 85% of patients with no differences between ACL-deficient and ACL-intact knees at a mean follow-up of nine years. Cite this article: Bone Joint J 2021;103-B(8):1367-1372.
引用
- Plancher KD, Brite JE, Briggs KK, et al. Patient-acceptable symptom state for reporting outcomes following unicompartmental knee arthroplasty : a matched pair analysis comparing UKA in ACL-deficient versus ACL-intact knees. Bone Joint J. 2021. PMID: 34334042. doi:10.1302/0301-620X.103B8.BJJ-2021-0170.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。